The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
Status:
Completed
Trial end date:
2021-04-21
Target enrollment:
Participant gender:
Summary
The study will examine the impact on cognitive reserve of a pharmacist-physician
patient-centered medication therapy management intervention to address inappropriate
medication use as identified by the Beers 2015 list. By bolstering cognitive reserve, this
project will directly address the National Alzheimer's Project Act 2015 priorities serving to
delay onset of symptoms in preclinical dementia. The results of this study will provide
valuable insights on how to expand this intervention to reduce the prevalence and associated
healthcare costs of symptomatic Alzheimer's disease.